Safety and 30-day outcomes of tracheostomy for COVID-19: a prospective observational cohort studyOmar Breik, Laura Tasker, Neil Sharma et al.|British Journal of Anaesthesia|2020Cited by 125
Landiolol and Organ Failure in Patients With Septic ShockTony Whitehouse, Hazel Smith, Md. Anower Hossain et al.|JAMA|2023Cited by 97
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trialBenjamin A. Fisher, K Turner, Tonny Veenith et al.|UCL Discovery (University College London)|2022Cited by 58
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort studyHamish McAuley, A Alamoudi, Michael Marks et al.|EClinicalMedicine|2023Cited by 24
Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trialBenjamin A. Fisher, Pamela Kearns, Tonny Veenith et al.|medRxiv|2021Cited by 7